BAXALTA
Baxalta Incorporated
Trademark Registered: 2016-05-24
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79165660 |
| Registration Number | 4961987 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Karl M. Zielaznicki, Esq. |
| Law Office Assigned | L50 |
| Employee Name | CARLSON, KRISTIN ELIZA |
Timeline
| 2015-02-25 | Application Filed |
| 2016-03-08 | Published for Opposition |
| 2016-05-24 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-05-24 | Status: Live/Registered |
| 2016-05-24 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Baxalta Incorporated |
| Address | 1200 Lakeside Drive Bannockburn DE 60015 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 16 |
| U.S. Codes: | 002,005,022,023,029,037,038,050 |
| International Codes: | 38 |
| U.S. Codes: | 100,101,104 |
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, substances and products for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceuticals for the treatment of blood diseases and disorders, immuno deficiency disorders, cancer; pharmaceutical preparations, namely, proteinase inhibitors in the nature of alpha-1 proteinase inhibitors; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, all containing immune globulin infusion (human) and recombinant human hyaluronidase; reconstitution assembly sold containing vials prefilled with pharmaceutical preparations for the treatment of blood diseases and disorders; normal serum albumin (human) solution for intravenous administration; immunoglobulin for parenteral, intramuscular and intravenous administration to humans; antihemophilic factor for intravenous administration in humans; antihemophilic factor recombinant; pharmaceutical preparations, namely, chemotherapeutic agents |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2015-05-30 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-06-01 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2015-06-02 | 3 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2015-06-05 | 4 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2015-06-05 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2015-06-06 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2015-06-09 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2015-06-09 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2015-06-27 | 9 RFNT P: |
| CHANGE OF OWNER RECEIVED FROM IB | 2015-07-31 | 10 CHLD M: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2015-10-01 | 11 NREP P: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2015-11-19 | 12 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2015-11-19 | 13 ARAA I:Incoming Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-12-04 | 14 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2015-12-18 | 15 ALIE A:Allowance for Publication |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2015-12-19 | 16 CHAN I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-12-19 | 17 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-12-19 | 18 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2016-01-11 | 19 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2016-01-11 | 20 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2016-01-11 | 21 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2016-01-14 | 22 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-01-14 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-01-15 | 24 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-01-27 | 25 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2016-02-03 | 26 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-02-17 | 27 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2016-02-17 | 28 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2016-02-17 | 29 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2016-03-04 | 30 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2016-03-08 | 31 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-03-08 | 32 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2016-05-24 | 33 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2016-08-24 | 34 FICR P: |
| FINAL DISPOSITION PROCESSED | 2016-08-25 | 35 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2016-08-25 | 36 FICS P: |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2016-09-15 | 37 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2016-09-15 | 38 ARAA I:Incoming Correspondence |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2017-04-08 | 39 FINO P: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2021-05-24 | 40 REM3 E:E-Mail |
| TEAS SECTION 71 RECEIVED | 2022-05-23 | 41 ES71 I:Incoming Correspondence |
| NEW REPRESENTATIVE AT IB RECEIVED | 2022-10-21 | 42 NREP P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2022-10-22 | 43 NREP P: |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-11-07 | 44 APRE A:Allowance for Publication |
| REGISTERED - PARTIAL SEC 71 ACCEPTED | 2022-12-01 | 45 71.P O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | 2022-12-01 | 46 NA71 E:E-Mail |
| PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | 2023-08-01 | 47 INPR P: |
| INVALIDATION PROCESSED | 2023-08-30 | 48 INPC P: |
| PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | 2023-08-30 | 49 INPS P: |
| PARTIAL INVALIDATION PROCESSED BY THE IB | 2023-10-15 | 50 INNP P: |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BAXALTA 79171327 5084124 Live/Registered |
Baxalta Incorporated 2015-05-12 |
 BAXALTA 79165660 4961987 Live/Registered |
Baxalta Incorporated 2015-02-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 